Cancer

1. BREEN KE, Vashisth S, Liu YL
   Cancer risks associated with BRCA1 and BRCA2: Overview and management.
   Cancer. 2026;132:e70635.
   

   >> Share

   
   

   
   Cancer Lett

2. REN Y, Yu T, Wang Z, Ma Y, et al
   Verbascoside inhibits ovarian cancer proliferation via IRAK4-CXCL5 axis-mediated suppression of neutrophil infiltration and neutrophil extracellular trap formation.
   Cancer Lett. 2026 Oct 16:218901. doi: 10.1016/j.canlet.2026.218901.
   

   >> Share

   
   

   
   Clin Cancer Res

3. BAZZARO M, Lin Z, Santillan A, Lee MK, et al
   Editor's Note: Ubiquitin Proteasome System Stress Underlies Synergistic Killing of Ovarian Cancer Cells by Bortezomib and a Novel HDAC6 Inhibitor.
   Clin Cancer Res. 2026;32:4755.
   

   >> Share

   
   
4. LI Z, Zhou W, Zhang Y, Sun W, et al
   Editor's Note: ERK Regulates HIF1alpha-Mediated Platinum Resistance by Directly Targeting PHD2 in Ovarian Cancer.
   Clin Cancer Res. 2026;32:4754.
   

   >> Share

   
   

   
   Gynecol Oncol

5. SALOMON C, Lai A, Guanzon D, Scholz-Romero K, et al
   Immunoaffinity-enriched extracellular vesicle proteomics for high-grade serous ovarian cancer - A UKOPS nested case-control analysis.
   Gynecol Oncol. 2026;214:94-101.
   

   >> Share

   
   

   
   Nat Med

6. SELLARS MC, Frank JA, Shim B, Vanasse A, et al
   Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial.
   Nat Med. 2026 Oct 14. doi: 10.1038/s41591-026-04717.
   

   >> Share

   
   

   
   Obstet Gynecol

7. WONG SM, Kotsopoulos J
   Rethinking Menopausal Hormone Therapy After Risk-Reducing Salpingo-Oophorectomy in Women at High Risk for Breast Cancer.
   Obstet Gynecol. 2026 Sep 15. doi: 10.1097/AOG.0000000000006429.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share